You are here: Industry Insights > antibody

News List

Pharmaceutical News of the Week (July. 13th-July. 17th) | PharmaSources.com - Updates on R&D PharmaSources/Caicai
July 22, 2020
With the third week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions, and miscellany that happened during July 13-17, including 30 pieces.
Pharmaceutical News of the Week (July. 6th-July. 10th) | PharmaSources.com - Updates on R&D PharmaSources/Caicai
July 21, 2020
With the second week of July coming to a close, let’s review the hot events of the pharmaceutical industry this week. The news involved 6 sections: approval, R&D, policies, transactions, listing and miscellany that happened during July 6-10.
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on Approvals PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
Second ADC Therapeutic Drug Was Approved for Marketing in China CPhI.CN
May 14, 2020
Takeda Pharmaceutical's application of vebutuximab for injection has been approved and became the second ADC drug approved in the Chinese market.
Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange PharmaSources.com
February 18, 2022
The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157), today announced the proposed listing...
Novel antibody helps block COVID transmission in cells, finds study ExpressPharma
February 15, 2022
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells.
FDA grants EUA to Lilly’s bebtelovimab for Covid-19 treatment Pharmaceutical-Technology
February 15, 2022
Bebtelovimab is indicated for treating mild-to-moderate Covid-19 in adults and paediatric patients aged 12 years and above.
Scientists identified vulnerable site on multiple coronaviruses WorldPharmaNews
February 11, 2022
The COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the base of its spike protein that is found also on closely related coronaviruses, according to a new study from Scripps Research.
New Covid-19 treatment drug available for use in Ireland FirstWordPharma
January 28, 2022
Ireland has agreed a supply deal for GlaxoSmithKline's COVID-19 antibody treatment Xevudy (sotrovimab), reported The Irish Times.
Feds may limit authorizating monoclonal antibody treatments FirstWordPharma
January 24, 2022
According to a source familiar with the decision-making, US regulators are considering limiting the authorization of certain monoclonal antibody treatments for COVID-19 that have not proved effective against the Omicron variant, reported CNN.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page